Jim Anderson, MPAS, PA-C, explores the role and limits of guidelines. He notes: Whether these practice aids are considered friends or foes, they can never eliminate the inevitable gray areas.
An immunologist proposes a standard definition for “disease modification” in systemic lupus erythematosus to establish treatment targets in clinical trials and clinical practice.
Lloyd S. Miller, MD, PhD, writes about understanding the overlapping immune pathways between psoriasis and psoriatic arthritis that may be useful to develop treatment plans for patients with these conditions.
John Botson, MD, provides his perspective on including immunodulatory therapy in combination with pegloticase and encourages clinicians to evolve their standard of care in the treatment of uncontrolled gout.
Jim Anderson, MPAS, PA-C, explores COVID-19 fatigue and how it is all a bit numbing for medical providers who are trying to do their best to treat patients while clinging to trusted sources to help guide the way.
Case study of a 70-year-old man who presents with vague signs of a rheumatic disease.
The authors describe how to diagnose and treat comorbid cardiogenic shock and COVID-19 in this case study.
Case study of a woman with a rare cardiac manifestation of a rheumatic disease.
Case study of a 37-year-old woman with a unique presentation of an inflammatory disease.
A 19-year-old woman presents with complaints of progressive shortness of breath, chest pain, and lower extremity edema over the past month.